ExploreWatchlistsPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Cash from financing

KISSEI PHARMACEUTICAL CO.,LTD. (4547)

Market cap
¥230.7B
P/E ratio
15.8x
Kissei Pharmaceutical develops and manufactures prescription drugs while also operating subsidiaries in food products, IT services, and construction.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Mar 31, 2025-9,325-6.81%
Mar 31, 2024-10,006+192.57%
Mar 31, 2023-3,420+24.09%
Mar 31, 2022-2,756-31.10%
Mar 31, 2021-4,000-9.48%
Mar 31, 2020-4,419+91.63%
Mar 31, 2019-2,306-65.17%
Mar 31, 2018-6,621+75.81%
Mar 31, 2017-3,766+75.49%
Mar 31, 2016-2,146-78.71%
Mar 31, 2015-10,081

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat